MoneyMarketWatch
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
The Federal Trade Commission and seven states say Shkreli should be held in contempt
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The Federal Trade Commission and seven states say Shkreli should be held in contempt
Join the argument
House rules →Comments load as you scroll.